Reports
Reports
As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.
Sale
The global neuromodulation devices industry attained a value of USD 6 billion in 2020. The market is further expected to grow in the forecast period of 2021-2026 at a CAGR of 9% to reach USD 10 billion by 2026.
The North American region is one of the largest markets for neuromodulation devices. The reason is attributed to the higher rate of diagnosis for related diseases and their usage for chronic illness. The presence of major players in United States is also contributing to the large demand. Europe has properly developed healthcare sector with high per capita medical expenditure. The increasing approval for non-invasive devices is fueling the market demand in the region. Asia Pacific will have significant growth rate because of the rising population, economic development, and expanding healthcare infrastructure.
Neuromodulation devices are ones that act directly upon nerves by alteration of nerve activity. This is done with the help of providing the pharmaceutical or electrical agents to the desired area directly. They can be used for treatment of various diseases such as headaches, chronic pain relief, dystonia, and Parkinson’s disease.
On the basis of type, neuromodulation devices are divided into:
The neuromodulation devices are segmented on the basis of product into:
On the basis of biomaterial, the industry is segmented into:
On the grounds of application, market is divided into:
The end use segments for neuromodulation devices are the following:
The regional markets for custom shoes industry can be divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
The neuromodulation devices are finding numerous applications in the healthcare sector. They are being increasingly used for chronic pain relief, epilepsy, depression, Parkinson’s disease, and other health problems. Their high efficacy in the treatment is leading to a spurt in the demand for neuromodulation devices. The major players in the market have been investing in research and development for improving the technology. This will lead to better treatment effect and more applications and hence accelerate the growth of the industry. The rise in chronic pain patients is also propelling the market demand.
The report gives a detailed analysis of the following key players in the global neuromodulation devices market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
The comprehensive EMR report provides an in-depth assessment of the industry based on the Porter's five forces model along with giving a SWOT analysis.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global Neuromodulation Devices Market Analysis
8.1 Key Industry Highlights
8.2 Global Neuromodulation Devices Historical Market (2016-2020)
8.3 Global Neuromodulation Devices Market Forecast (2021-2026)
8.4 Global Neuromodulation Devices Market by Type
8.4.1 Internal Neuromodulation
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2016-2020)
8.4.1.3 Forecast Trend (2021-2026)
8.4.2 External Neuromodulation
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2016-2020)
8.4.2.3 Forecast Trend (2021-2026)
8.5 Global Neuromodulation Devices Market by Product
8.5.1 Spinal Cord Stimulators
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2016-2020)
8.5.1.3 Forecast Trend (2021-2026)
8.5.2 Deep Brain Stimulators
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2016-2020)
8.5.2.3 Forecast Trend (2021-2026)
8.5.3 Vagus Nerve Stimulators
8.5.3.1 Market Share
8.5.3.2 Historical Trend (2016-2020)
8.5.3.3 Forecast Trend (2021-2026)
8.5.4 Sacral Nerve Stimulators
8.5.4.1 Market Share
8.5.4.2 Historical Trend (2016-2020)
8.5.4.3 Forecast Trend (2021-2026)
8.5.5 Gastric Electrical Stimulation
8.5.5.1 Market Share
8.5.5.2 Historical Trend (2016-2020)
8.5.5.3 Forecast Trend (2021-2026)
8.5.6 Transcranial Magnetic Stimulation
8.5.6.1 Market Share
8.5.6.2 Historical Trend (2016-2020)
8.5.6.3 Forecast Trend (2021-2026)
8.5.7 Transcutaneous Electrical Nerve Stimulation Devices
8.5.7.1 Market Share
8.5.7.2 Historical Trend (2016-2020)
8.5.7.3 Forecast Trend (2021-2026)
8.5.8 Others
8.6 Global Neuromodulation Devices Market by Biomaterial
8.6.1 Ceramics Biomaterials
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2016-2020)
8.6.1.3 Forecast Trend (2021-2026)
8.6.2 Metallic Biomaterials
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2016-2020)
8.6.2.3 Forecast Trend (2021-2026)
8.6.3 Polymeric Biomaterials
8.6.3.1 Market Share
8.6.3.2 Historical Trend (2016-2020)
8.6.3.3 Forecast Trend (2021-2026)
8.7 Global Neuromodulation Devices Market by Application
8.7.1 Pain Management
8.7.1.1 Market Share
8.7.1.2 Historical Trend (2016-2020)
8.7.1.3 Forecast Trend (2021-2026)
8.7.2 Epilepsy
8.7.2.1 Market Share
8.7.2.2 Historical Trend (2016-2020)
8.7.2.3 Forecast Trend (2021-2026)
8.7.3 Essential Tremors
8.7.3.1 Market Share
8.7.3.2 Historical Trend (2016-2020)
8.7.3.3 Forecast Trend (2021-2026)
8.7.4 Urinary and Fecal Incontinence
8.7.4.1 Market Share
8.7.4.2 Historical Trend (2016-2020)
8.7.4.3 Forecast Trend (2021-2026)
8.7.5 Depression
8.7.5.1 Market Share
8.7.5.2 Historical Trend (2016-2020)
8.7.5.3 Forecast Trend (2021-2026)
8.7.6 Dystonia
8.7.6.1 Market Share
8.7.6.2 Historical Trend (2016-2020)
8.7.6.3 Forecast Trend (2021-2026)
8.7.7 Parkinson’s Disease
8.7.7.1 Market Share
8.7.7.2 Historical Trend (2016-2020)
8.7.7.3 Forecast Trend (2021-2026)
8.7.8 Others
8.8 Global Neuromodulation Devices Market by End Use
8.8.1 Rehabilitation Centres
8.8.1.1 Market Share
8.8.1.2 Historical Trend (2016-2020)
8.8.1.3 Forecast Trend (2021-2026)
8.8.2 Hospitals
8.8.2.1 Market Share
8.8.2.2 Historical Trend (2016-2020)
8.8.2.3 Forecast Trend (2021-2026)
8.8.3 Specialty Clinics
8.8.3.1 Market Share
8.8.3.2 Historical Trend (2016-2020)
8.8.3.3 Forecast Trend (2021-2026)
8.8.4 Others
8.9 Global Neuromodulation Devices Market by Region
8.9.1 Market Share
8.9.1.1 North America
8.9.1.2 Europe
8.9.1.3 Asia Pacific
8.9.1.4 Latin America
8.9.1.5 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2016-2020)
9.1.2 Forecast Trend (2021-2026)
9.1.3 Breakup by Country
9.1.3.1 United States of America
9.1.3.2 Canada
9.2 Europe
9.2.1 Historical Trend (2016-2020)
9.2.2 Forecast Trend (2021-2026)
9.2.3 Breakup by Country
9.2.3.1 United Kingdom
9.2.3.2 Germany
9.2.3.3 France
9.2.3.4 Italy
9.2.3.5 Others
9.3 Asia Pacific
9.3.1 Historical Trend (2016-2020)
9.3.2 Forecast Trend (2021-2026)
9.3.3 Breakup by Country
9.3.3.1 China
9.3.3.2 Japan
9.3.3.3 India
9.3.3.4 ASEAN
9.3.3.5 Australia
9.3.3.6 Others
9.4 Latin America
9.4.1 Historical Trend (2016-2020)
9.4.2 Forecast Trend (2021-2026)
9.4.3 Breakup by Country
9.4.3.1 Brazil
9.4.3.2 Argentina
9.4.3.3 Mexico
9.4.3.4 Others
9.5 Middle East and Africa
9.5.1 Historical Trend (2016-2020)
9.5.2 Forecast Trend (2021-2026)
9.5.3 Breakup by Country
9.5.3.1 Saudi Arabia
9.5.3.2 United Arab Emirates
9.5.3.3 Nigeria
9.5.3.4 South Africa
9.5.3.5 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 EMR’s Key Indicators for Demand
10.4 EMR’s Key Indicators for Price
11 Value Chain Analysis
12 Competitive Landscape
12.1 Market Structure
12.2 Company Profiles
12.2.1 electroCore, Inc.
12.2.1.1 Company Overview
12.2.1.2 Product Portfolio
12.2.1.3 Demographic Reach and Achievements
12.2.1.4 Certifications
12.2.2 Boston Scientific Corporation
12.2.2.1 Company Overview
12.2.2.2 Product Portfolio
12.2.2.3 Demographic Reach and Achievements
12.2.2.4 Certifications
12.2.3 Medtronic, plc
12.2.3.1 Company Overview
12.2.3.2 Product Portfolio
12.2.3.3 Demographic Reach and Achievements
12.2.3.4 Certifications
12.2.4 Abbott Laboratories
12.2.4.1 Company Overview
12.2.4.2 Product Portfolio
12.2.4.3 Demographic Reach and Achievements
12.2.4.4 Certifications
12.2.5 Synapse Biomedical Inc.
12.2.5.1 Company Overview
12.2.5.2 Product Portfolio
12.2.5.3 Demographic Reach and Achievements
12.2.5.4 Certifications
12.2.6 Bioness Inc.
12.2.6.1 Company Overview
12.2.6.2 Product Portfolio
12.2.6.3 Demographic Reach and Achievements
12.2.6.4 Certifications
12.2.7 Others
13 Industry Events and Developments
List of Figures and Tables
1. Global Neuromodulation Devices Market: Key Industry Highlights, 2016 and 2026
2. Global Neuromodulation Devices Historical Market: Breakup by Type (USD Million), 2016-2020
3. Global Neuromodulation Devices Market Forecast: Breakup by Type (USD Million), 2021-2026
4. Global Neuromodulation Devices Historical Market: Breakup by Product (USD Million), 2016-2020
5. Global Neuromodulation Devices Market Forecast: Breakup by Product (USD Million), 2021-2026
6. Global Neuromodulation Devices Historical Market: Breakup by Biomaterial (USD Million), 2016-2020
7. Global Neuromodulation Devices Market Forecast: Breakup by Biomaterial (USD Million), 2021-2026
8. Global Neuromodulation Devices Historical Market: Breakup by Application (USD Million), 2016-2020
9. Global Neuromodulation Devices Market Forecast: Breakup by Application (USD Million), 2021-2026
10. Global Neuromodulation Devices Historical Market: Breakup by End Use (USD Million), 2016-2020
11. Global Neuromodulation Devices Market Forecast: Breakup by End Use (USD Million), 2021-2026
12. Global Neuromodulation Devices Historical Market: Breakup by Region (USD Million), 2016-2020
13. Global Neuromodulation Devices Market Forecast: Breakup by Region (USD Million), 2021-2026
14. North America Neuromodulation Devices Historical Market: Breakup by Country (USD Million), 2016-2020
15. North America Neuromodulation Devices Market Forecast: Breakup by Country (USD Million), 2021-2026
16. Europe Neuromodulation Devices Historical Market: Breakup by Country (USD Million), 2016-2020
17. Europe Neuromodulation Devices Market Forecast: Breakup by Country (USD Million), 2021-2026
18. Asia Pacific Neuromodulation Devices Historical Market: Breakup by Country (USD Million), 2016-2020
19. Asia Pacific Neuromodulation Devices Market Forecast: Breakup by Country (USD Million), 2021-2026
20. Latin America Neuromodulation Devices Historical Market: Breakup by Country (USD Million), 2016-2020
21. Latin America Neuromodulation Devices Market Forecast: Breakup by Country (USD Million), 2021-2026
22. Middle East and Africa Neuromodulation Devices Historical Market: Breakup by Country (USD Million), 2016-2020
23. Middle East and Africa Neuromodulation Devices Market Forecast: Breakup by Country (USD Million), 2021-2026
24. Global Neuromodulation Devices Market Structure
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
RIGHT PEOPLE
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
RIGHT METHODOLOGY
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
RIGHT PRICE
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
RIGHT SUPPORT
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.